{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:59:12Z","timestamp":1792317552786,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH49334"],"award-info":[{"award-number":["R01MH49334"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG041795"],"award-info":[{"award-number":["R01 AG041795"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG026158"],"award-info":[{"award-number":["R01-AG026158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Amyloid deposition is a primary predictor of Alzheimer\u2019s disease (AD) and related neurodegenerative disorders. Retinal changes involving the structure and function of the ganglion cell layer are increasingly documented in both established and prodromal AD. Visual event-related potentials (vERP) are sensitive to dysfunction in the magno- and parvocellular visual systems, which originate within the retinal ganglion cell layer. The present study evaluates vERP as a function of amyloid deposition in aging, and in mild cognitive impairment (MCI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>vERP to stimulus-onset, motion-onset, and alpha-frequency steady-state (ssVEP) stimuli were obtained from 16 amyloid-positive and 41 amyloid-negative healthy elders and 15 MCI individuals and analyzed using time\u2013frequency approaches. Social cognition was assessed in a subset of individuals using The Awareness of Social Inference Test (TASIT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Neurocognitively intact but amyloid-positive participants and MCI individuals showed significant deficits in stimulus-onset (theta) and motion-onset (delta) vERP generation relative to amyloid-negative participants (all <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.01). Across healthy elders, a composite index of these measures correlated highly (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2009\u2212\u2009.52, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001) with amyloid standardized uptake value ratios (SUVR) and TASIT performance. A composite index composed of vERP measures significant differentiated amyloid-positive and amyloid-negative groups with an overall classification accuracy of\u2009&gt;\u200970%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>vERP may assist in the early detection of amyloid deposition among older individuals without observable neurocognitive impairments and in linking previously documented retinal deficits in both prodromal AD and MCI to behavioral impairments in social cognition.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-023-01189-7","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:30:14Z","timestamp":1677756614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment"],"prefix":"10.1186","volume":"15","author":[{"given":"Daniel C.","family":"Javitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigona","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Sehatpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Beloborodova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Habeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunglin","family":"Gazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton","family":"Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qolamreza R.","family":"Razlighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. P.","family":"Devanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaakov","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"issue":"1","key":"1189_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1474-4422(15)00323-3","volume":"15","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Therneau TM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, et al. Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. Lancet Neurol. 2016;15(1):56\u201364.","journal-title":"Lancet Neurol"},{"key":"1189_CR2","doi-asserted-by":"crossref","unstructured":"Carbonell F, Zijdenbos AP, Charil A, Grand\u2019Maison M, Bedell BJ, Alzheimer\u2019s Disease Neuroimaging I. Optimal target region for subject classification on the basis of amyloid PET images. J Nucl Med. 2015;56(9):1351\u20138.","DOI":"10.2967\/jnumed.115.158774"},{"issue":"19","key":"1189_CR3","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015;313(19):1924\u201338.","journal-title":"JAMA"},{"issue":"11","key":"1189_CR4","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jalz.2019.09.075","volume":"16","author":"M Tolar","year":"2020","unstructured":"Tolar M, Abushakra S, Sabbagh M. The path forward in Alzheimer\u2019s disease therapeutics: reevaluating the amyloid cascade hypothesis. Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association. 2020;16(11):1553\u201360.","journal-title":"Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association"},{"issue":"4","key":"1189_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14737159.2020.1731306","volume":"20","author":"F Baldacci","year":"2020","unstructured":"Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, et al. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Rev Mol Diagn. 2020;20(4):421\u201341.","journal-title":"Expert Rev Mol Diagn"},{"key":"1189_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.pmbts.2019.07.006","volume":"168","author":"K Blennow","year":"2019","unstructured":"Blennow K, Zetterberg H. Fluid biomarker-based molecular phenotyping of Alzheimer\u2019s disease patients in research and clinical settings. Prog Mol Biol Transl Sci. 2019;168:3\u201323.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"5","key":"1189_CR7","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/ijms23052486","volume":"23","author":"D Romaus-Sanjurjo","year":"2022","unstructured":"Romaus-Sanjurjo D, Regueiro U, Lopez-Lopez M, Vazquez-Vazquez L, Ouro A, Lema I, et al. Alzheimer\u2019s disease seen through the eye: ocular alterations and neurodegeneration. Int J Mol Sci. 2022;23(5):2486.","journal-title":"Int J Mol Sci."},{"key":"1189_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101361","volume":"69","author":"YJ Ge","year":"2021","unstructured":"Ge YJ, Xu W, Ou YN, Qu Y, Ma YH, Huang YY, et al. Retinal biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. Ageing Res Rev. 2021;69: 101361.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1189_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/ADR-210283","volume":"5","author":"S Fereshetian","year":"2021","unstructured":"Fereshetian S, Agranat JS, Siegel N, Ness S, Stein TD, Subramanian ML. Protein and imaging biomarkers in the eye for early detection of Alzheimer\u2019s disease. J Alzheimers Dis Rep. 2021;5(1):375\u201387.","journal-title":"J Alzheimers Dis Rep"},{"key":"1189_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100899","volume":"82","author":"VB Gupta","year":"2021","unstructured":"Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, et al. Retinal changes in Alzheimer\u2019s disease- integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res. 2021;82:100899.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1189_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-022-01008-5","volume":"14","author":"I L\u00f3pez-Cuenca","year":"2022","unstructured":"L\u00f3pez-Cuenca I, Marcos-Dolado A, Yus-Fuertes M, Salobrar-Garc\u00eda E, Elvira-Hurtado L, Fern\u00e1ndez-Albarral JA, et al. The relationship between retinal layers and brain areas in asymptomatic first-degree relatives of sporadic forms of Alzheimer\u2019s disease: an exploratory analysis. Alzheimers Res Therapy. 2022;14(1):1\u201318.","journal-title":"Alzheimers Res Therapy"},{"issue":"10","key":"1189_CR12","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/S1388-2457(01)00620-4","volume":"112","author":"V Parisi","year":"2001","unstructured":"Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer\u2019s disease patients. Clin Neurophysiol. 2001;112(10):1860\u20137.","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"1189_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10633-010-9238-x","volume":"121","author":"K Krasodomska","year":"2010","unstructured":"Krasodomska K, Lubinski W, Potemkowski A, Honczarenko K. Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer\u2019s disease. Doc Ophthalmol. 2010;121(2):111\u201321.","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"1189_CR14","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1038\/s41598-021-85010-1","volume":"11","author":"S Asanad","year":"2021","unstructured":"Asanad S, Felix CM, Fantini M, Harrington MG, Sadun AA, Karanjia R. Retinal ganglion cell dysfunction in preclinical Alzheimer\u2019s disease: an electrophysiologic biomarker signature. Sci Rep. 2021;11(1):6344.","journal-title":"Sci Rep"},{"issue":"5","key":"1189_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaophthalmol.2021.0320","volume":"139","author":"MS Byun","year":"2021","unstructured":"Byun MS, Park SW, Lee JH, Yi D, Jeon SY, Choi HJ, et al. Association of retinal changes with Alzheimer disease neuroimaging biomarkers in cognitively normal individuals. JAMA Ophthalmol. 2021;139(5):548\u201356.","journal-title":"JAMA Ophthalmol"},{"key":"1189_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijpsycho.2020.06.001","volume":"155","author":"EE Tulay","year":"2020","unstructured":"Tulay EE, Guntekin B, Yener G, Bayram A, Basar-Eroglu C, Demiralp T. Evoked and induced EEG oscillations to visual targets reveal a differential pattern of change along the spectrum of cognitive decline in Alzheimer\u2019s disease. Int J Psychophysiol. 2020;155:41\u20138.","journal-title":"Int J Psychophysiol"},{"key":"1189_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.visres.2020.05.003","volume":"174","author":"J Kremers","year":"2020","unstructured":"Kremers J, McKeefry DJ, Murray IJ, Parry NRA. Developments in non-invasive visual electrophysiology. Vision Res. 2020;174:50\u20136.","journal-title":"Vision Res"},{"issue":"Pt 2","key":"1189_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/brain\/awl233","volume":"130","author":"PD Butler","year":"2007","unstructured":"Butler PD, Martinez A, Foxe JJ, Kim D, Zemon V, Silipo G, et al. Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments. Brain. 2007;130(Pt 2):417\u201330.","journal-title":"Brain"},{"issue":"2","key":"1189_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/hbm.10010","volume":"15","author":"F Di Russo","year":"2002","unstructured":"Di Russo F, Martinez A, Sereno MI, Pitzalis S, Hillyard SA. Cortical sources of the early components of the visual evoked potential. Hum Brain Mapp. 2002;15(2):95\u2013111.","journal-title":"Hum Brain Mapp"},{"issue":"11","key":"1189_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/archpsyc.59.11.1011","volume":"59","author":"GM Doniger","year":"2002","unstructured":"Doniger GM, Foxe JJ, Murray MM, Higgins BA, Javitt DC. Impaired visual object recognition and dorsal\/ventral stream interaction in schizophrenia. Arch Gen Psychiatry. 2002;59(11):1011\u201320.","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"1189_CR21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archpsyc.64.11.1229","volume":"64","author":"C Haenschel","year":"2007","unstructured":"Haenschel C, Bittner RA, Haertling F, Rotarska-Jagiela A, Maurer K, Singer W, et al. Contribution of impaired early-stage visual processing to working memory dysfunction in adolescents with schizophrenia: a study with event-related potentials and functional magnetic resonance imaging. Arch Gen Psychiatry. 2007;64(11):1229\u201340.","journal-title":"Arch Gen Psychiatry"},{"issue":"1\u20133","key":"1189_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.schres.2007.05.001","volume":"94","author":"BI Turetsky","year":"2007","unstructured":"Turetsky BI, Kohler CG, Indersmitten T, Bhati MT, Charbonnier D, Gur RC. Facial emotion recognition in schizophrenia: when and why does it go awry? Schizophr Res. 2007;94(1\u20133):253\u201363.","journal-title":"Schizophr Res"},{"issue":"1","key":"1189_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/schbul\/sbaa107","volume":"47","author":"EC Dias","year":"2021","unstructured":"Dias EC, Sheridan H, Martinez A, Sehatpour P, Silipo G, Rohrig S, et al. Neurophysiological, oculomotor, and computational modeling of impaired reading ability in schizophrenia. Schizophr Bull. 2021;47(1):97\u2013107.","journal-title":"Schizophr Bull"},{"issue":"7","key":"1189_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/02713683.2018.1459730","volume":"43","author":"J Nguyen","year":"2018","unstructured":"Nguyen J, Rothman A, Fitzgerald K, Whetstone A, Syc-Mazurek S, Aquino J, et al. Visual pathway measures are associated with neuropsychological function in multiple sclerosis. Curr Eye Res. 2018;43(7):941\u20138.","journal-title":"Curr Eye Res"},{"issue":"7","key":"1189_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biopsych.2019.05.016","volume":"86","author":"A Martinez","year":"2019","unstructured":"Martinez A, Tobe R, Dias EC, Ardekani BA, Veenstra-VanderWeele J, Patel G, et al. Differential patterns of visual sensory alteration underlying face emotion recognition impairment and motion perception deficits in schizophrenia and autism spectrum disorder. Biol Psychiatry. 2019;86(7):557\u201367.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"1189_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.visres.2006.09.020","volume":"47","author":"M Kuba","year":"2007","unstructured":"Kuba M, Kubov\u00e1 Z, Kreml\u00e1\u010dek J, Langrov\u00e1 J. Motion-onset VEPs: characteristics, methods, and diagnostic use. Vision Res. 2007;47(2):189\u2013202.","journal-title":"Vision Res"},{"issue":"9","key":"1189_CR27","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41386-020-0697-9","volume":"45","author":"DC Javitt","year":"2020","unstructured":"Javitt DC, Siegel SJ, Spencer KM, Mathalon DH, Hong LE, Martinez A, et al. A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology. Neuropsychopharmacol. 2020;45(9):1411\u201322.","journal-title":"Neuropsychopharmacol"},{"issue":"12","key":"1189_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1176\/appi.ajp.2018.18010072","volume":"175","author":"A Martinez","year":"2018","unstructured":"Martinez A, Gaspar PA, Hillyard SA, Andersen SK, Lopez-Calderon J, Corcoran CM, et al. Impaired motion processing in schizophrenia and the attenuated psychosis syndrome: etiological and clinical implications. Am J Psychiatry. 2018;175(12):1243\u201354.","journal-title":"Am J Psychiatry"},{"issue":"24","key":"1189_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1080\/09638280600646185","volume":"28","author":"S McDonald","year":"2006","unstructured":"McDonald S, Bornhofen C, Shum D, Long E, Saunders C, Neulinger K. Reliability and validity of The Awareness of Social Inference Test (TASIT): a clinical test of social perception. Disabil Rehabil. 2006;28(24):1529\u201342.","journal-title":"Disabil Rehabil"},{"issue":"2","key":"1189_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/schbul\/sbv056","volume":"42","author":"AE Pinkham","year":"2016","unstructured":"Pinkham AE, Penn DL, Green MF, Harvey PD. Social cognition psychometric evaluation: results of the initial psychometric study. Schizophr Bull. 2016;42(2):494\u2013504.","journal-title":"Schizophr Bull"},{"key":"1189_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/schbul\/sbx117","volume":"44","author":"AE Pinkham","year":"2017","unstructured":"Pinkham AE, Harvey PD, Penn DL. Social cognition psychometric evaluation: results of the final validation study. Schizophr Bull. 2017;44:737.","journal-title":"Schizophr Bull."},{"key":"1189_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.547189","volume":"11","author":"P Sehatpour","year":"2020","unstructured":"Sehatpour P, Bassir Nia A, Adair D, Wang Z, DeBaun HM, Silipo G, et al. Multimodal computational modeling of visual object recognition deficits but intact repetition priming in schizophrenia. Front Psychiatry. 2020;11:547189.","journal-title":"Front Psychiatry"},{"key":"1189_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nicl.2012.09.006","volume":"2","author":"A Martinez","year":"2012","unstructured":"Martinez A, Revheim N, Butler PD, Guilfoyle DN, Dias EC, Javitt DC. Impaired magnocellular\/dorsal stream activation predicts impaired reading ability in schizophrenia. NeuroImage Clinical. 2012;2:8\u201316.","journal-title":"NeuroImage Clinical"},{"issue":"6","key":"1189_CR34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/schbul\/sbp109","volume":"35","author":"PD Butler","year":"2009","unstructured":"Butler PD, Abeles IY, Weiskopf NG, Tambini A, Jalbrzikowski M, Legatt ME, et al. Sensory contributions to impaired emotion processing in schizophrenia. Schizophr Bull. 2009;35(6):1095\u2013107.","journal-title":"Schizophr Bull"},{"key":"1189_CR35","doi-asserted-by":"crossref","unstructured":"Patel GH, Arkin SC, Ruiz-Betancourt DR, DeBaun HM, Strauss NE, Bartel LP, et al. What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia. Psychol Med. 2020:1\u201310.","DOI":"10.1017\/S0033291720001646"},{"issue":"6","key":"1189_CR36","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/brain\/awab081","volume":"144","author":"GH Patel","year":"2021","unstructured":"Patel GH, Arkin SC, Ruiz-Betancourt DR, Plaza FI, Mirza SA, Vieira DJ, et al. Failure to engage the temporoparietal junction\/posterior superior temporal sulcus predicts impaired naturalistic social cognition in schizophrenia. Brain. 2021;144(6):1898\u2013910.","journal-title":"Brain"},{"issue":"1","key":"1189_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/13825585.2015.1048773","volume":"23","author":"LM Lavrencic","year":"2016","unstructured":"Lavrencic LM, Kurylowicz L, Valenzuela MJ, Churches OF, Keage HA. Social cognition is not associated with cognitive reserve in older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016;23(1):61\u201377.","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"issue":"8","key":"1189_CR38","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/arclin\/acac027","volume":"37","author":"AK Martin","year":"2022","unstructured":"Martin AK, Ceslis A, Robinson GA. Social inference from middle to older adulthood. Arch Clin Neuropsychol. 2022;37(8):1653\u201361.","journal-title":"Arch Clin Neuropsychol"},{"issue":"12","key":"1189_CR39","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1037\/dev0000063","volume":"51","author":"LH Phillips","year":"2015","unstructured":"Phillips LH, Allen R, Bull R, Hering A, Kliegel M, Channon S. Older adults have difficulty in decoding sarcasm. Dev Psychol. 2015;51(12):1840\u201352.","journal-title":"Dev Psychol"},{"issue":"4","key":"1189_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/13854046.2017.1400106","volume":"32","author":"S McDonald","year":"2018","unstructured":"McDonald S, Honan C, Allen SK, El-Helou R, Kelly M, Kumfor F, et al. Normal adult and adolescent performance on TASIT-S, a short version of The Assessment of Social Inference Test. Clin Neuropsychol. 2018;32(4):700\u201319.","journal-title":"Clin Neuropsychol"},{"key":"1189_CR41","unstructured":"Mattis S. Dementia Rating Scale (DRS). Odessa, FL: Psychological Assessment Resources; 1988."},{"issue":"11","key":"1189_CR42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1212\/WNL.24.11.1019","volume":"24","author":"H Buschke","year":"1974","unstructured":"Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24(11):1019\u201325.","journal-title":"Neurology"},{"issue":"3","key":"1189_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dementia. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dementia"},{"issue":"4","key":"1189_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/WNP.0000000000000317","volume":"33","author":"JN Acharya","year":"2016","unstructured":"Acharya JN, Hani AJ, Thirumala PD, Tsuchida TN. American Clinical Neurophysiology Society Guideline 3: A proposal for standard montages to be used in clinical EEG. J Clin Neurophysiol. 2016;33(4):312\u20136.","journal-title":"J Clin Neurophysiol"},{"key":"1189_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fnhum.2014.00213","volume":"8","author":"J Lopez-Calderon","year":"2014","unstructured":"Lopez-Calderon J, Luck SJ. ERPLAB: an open-source toolbox for the analysis of event-related potentials. Front Hum Neurosci. 2014;8:213.","journal-title":"Front Hum Neurosci"},{"key":"1189_CR46","doi-asserted-by":"crossref","unstructured":"Knesaurek K, Warnock G, Kostakoglu L, Burger C, for Alzheimer\u2019s Disease Neouroimaging I. Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging. World J Nucl Med. 2018;17(1):21\u20136.","DOI":"10.4103\/wjnm.WJNM_5_17"},{"key":"1189_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2022.05.004","volume":"117","author":"PJ Lao","year":"2022","unstructured":"Lao PJ, Boehme AK, Morales C, Laing KK, Chesebro A, Igwe KC, et al. Amyloid, cerebrovascular disease, and neurodegeneration biomarkers are associated with cognitive trajectories in a racially and ethnically diverse, community-based sample. Neurobiol Aging. 2022;117:83\u201396.","journal-title":"Neurobiol Aging"},{"key":"1189_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.787383","volume":"15","author":"A Martinez","year":"2021","unstructured":"Martinez A, Tobe RH, Gaspar PA, Malinsky D, Dias EC, Sehatpour P, et al. Disease-specific contribution of pulvinar dysfunction to impaired emotion recognition in schizophrenia. Front Behav Neurosci. 2021;15: 787383.","journal-title":"Front Behav Neurosci"},{"key":"1189_CR49","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences, 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Assoc.; 1988."},{"issue":"Suppl 3","key":"1189_CR50","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.3233\/JAD-2012-112093","volume":"31","author":"T Yamasaki","year":"2012","unstructured":"Yamasaki T, Horie S, Muranaka H, Kaseda Y, Mimori Y, Tobimatsu S. Relevance of in vivo neurophysiological biomarkers for mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2012;31(Suppl 3):S137\u201354.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1189_CR51","first-page":"119","volume":"6","author":"A Yoonessi","year":"2011","unstructured":"Yoonessi A, Yoonessi A. Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications. J Ophthalmic Vis Res. 2011;6(2):119\u201326.","journal-title":"J Ophthalmic Vis Res"},{"issue":"3\u20134","key":"1189_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainresbull.2010.04.001","volume":"82","author":"F Sartucci","year":"2010","unstructured":"Sartucci F, Borghetti D, Bocci T, Murri L, Orsini P, Porciatti V, et al. Dysfunction of the magnocellular stream in Alzheimer\u2019s disease evaluated by pattern electroretinograms and visual evoked potentials. Brain Res Bull. 2010;82(3\u20134):169\u201376.","journal-title":"Brain Res Bull"},{"issue":"1","key":"1189_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1567205015666181022101036","volume":"16","author":"C Morrison","year":"2019","unstructured":"Morrison C, Rabipour S, Taler V, Sheppard C, Knoefel F. Visual event-related potentials in mild cognitive impairment and Alzheimer\u2019s disease: a literature review. Curr Alzheimer Res. 2019;16(1):67\u201389.","journal-title":"Curr Alzheimer Res"},{"key":"1189_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ncn3.12387","volume":"9","author":"T Yamasaki","year":"2021","unstructured":"Yamasaki T. Use of VEPs as electrodiagnostic biomarkers of mild cognitive impairment. Neurol Clin Neurosci. 2021;9:3\u20139.","journal-title":"Neurol Clin Neurosci"},{"key":"1189_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2014.08.038","volume":"1585","author":"GG Yener","year":"2014","unstructured":"Yener GG, Emek-Savas DD, Guntekin B, Basar E. The visual cognitive network, but not the visual sensory network, is affected in amnestic mild cognitive impairment: a study of brain oscillatory responses. Brain Res. 2014;1585:141\u20139.","journal-title":"Brain Res"},{"issue":"9","key":"1189_CR56","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1212\/WNL.41.9.1437","volume":"41","author":"GL Trick","year":"1991","unstructured":"Trick GL, Silverman SE. Visual sensitivity to motion: age-related changes and deficits in senile dementia of the Alzheimer type. Neurology. 1991;41(9):1437\u201340.","journal-title":"Neurology"},{"issue":"11","key":"1189_CR57","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/cercor\/11.11.1083","volume":"11","author":"HL O\u2019Brien","year":"2001","unstructured":"O\u2019Brien HL, Tetewsky SJ, Avery LM, Cushman LA, Makous W, Duffy CJ. Visual mechanisms of spatial disorientation in Alzheimer\u2019s disease. Cereb Cortex. 2001;11(11):1083\u201392.","journal-title":"Cereb Cortex"},{"issue":"3","key":"1189_CR58","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3233\/JAD-2011-110167","volume":"28","author":"T Yamasaki","year":"2012","unstructured":"Yamasaki T, Goto Y, Ohyagi Y, Monji A, Munetsuna S, Minohara M, et al. Selective impairment of optic flow perception in amnestic mild cognitive impairment: evidence from event-related potentials. J Alzheimers Dis. 2012;28(3):695\u2013708.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1189_CR59","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3233\/JAD-150939","volume":"53","author":"T Yamasaki","year":"2016","unstructured":"Yamasaki T, Horie S, Ohyagi Y, Tanaka E, Nakamura N, Goto Y, et al. A potential VEP biomarker for mild cognitive impairment: evidence from selective visual deficit of higher-level dorsal pathway. J Alzheimers Dis. 2016;53(2):661\u201376.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1189_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/JAD-122053","volume":"36","author":"R Fernandez","year":"2013","unstructured":"Fernandez R, Monacelli A, Duffy CJ. Visual motion event related potentials distinguish aging and Alzheimer\u2019s disease. J Alzheimers Dis. 2013;36(1):177\u201383.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1189_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10633-010-9230-5","volume":"121","author":"Z Kubova","year":"2010","unstructured":"Kubova Z, Kremlacek J, Valis M, Langrova J, Szanyi J, Vit F, et al. Visual evoked potentials to pattern, motion and cognitive stimuli in Alzheimer\u2019s disease. Doc Ophthalmol. 2010;121(1):37\u201349.","journal-title":"Doc Ophthalmol"},{"key":"1189_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134402","volume":"711","author":"T Yamasaki","year":"2019","unstructured":"Yamasaki T, Aso T, Kaseda Y, Mimori Y, Doi H, Matsuoka N, et al. Decreased stimulus-driven connectivity of the primary visual cortex during visual motion stimulation in amnestic mild cognitive impairment: An fMRI study. Neurosci Lett. 2019;711: 134402.","journal-title":"Neurosci Lett"},{"key":"1189_CR63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2018.03.017","volume":"67","author":"C Criscuolo","year":"2018","unstructured":"Criscuolo C, Cerri E, Fabiani C, Capsoni S, Cattaneo A, Domenici L. The retina as a window to early dysfunctions of Alzheimer\u2019s disease following studies with a 5xFAD mouse model. Neurobiol Aging. 2018;67:181\u20138.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1189_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/1567205018666210414113634","volume":"18","author":"L Guo","year":"2021","unstructured":"Guo L, Ravindran N, Shamsher E, Hill D, Cordeiro MF. Retinal changes in transgenic mouse models of Alzheimer\u2019s disease. Curr Alzheimer Res. 2021;18(2):89\u2013102.","journal-title":"Curr Alzheimer Res"},{"key":"1189_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neurobiolaging.2020.10.018","volume":"98","author":"A Karaduman","year":"2021","unstructured":"Karaduman A, Karoglu-Eravsar ET, Kaya U, Aydin A, Adams MM, Kafaligonul H. The optomotor response of aging zebrafish reveals a complex relationship between visual motion characteristics and cholinergic system. Neurobiol Aging. 2021;98:21\u201332.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1189_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11065-017-9345-5","volume":"27","author":"S Duke Han","year":"2017","unstructured":"Duke Han S, Nguyen CP, Stricker NH, Nation DA. Detectable neuropsychological differences in early preclinical Alzheimer\u2019s disease: a meta-analysis. Neuropsychol Rev. 2017;27(4):305\u201325.","journal-title":"Neuropsychol Rev"},{"key":"1189_CR67","doi-asserted-by":"crossref","unstructured":"Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, et al. Neurophysiological signatures in Alzheimer\u2019s disease are distinctly associated with TAU, amyloid-beta accumulation, and cognitive decline. Sci Transl Med. 2020;12(534):eaaz4069.","DOI":"10.1126\/scitranslmed.aaz4069"},{"issue":"4","key":"1189_CR68","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1017\/S0033291708003966","volume":"39","author":"RS Kern","year":"2009","unstructured":"Kern RS, Green MF, Fiske AP, Kee KS, Lee J, Sergi MJ, et al. Theory of mind deficits for processing counterfactual information in persons with chronic schizophrenia. Psychol Med. 2009;39(4):645\u201354.","journal-title":"Psychol Med"},{"issue":"10","key":"1189_CR69","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrn4005","volume":"16","author":"MF Green","year":"2015","unstructured":"Green MF, Horan WP, Lee J. Social cognition in schizophrenia. Nat Rev Neurosci. 2015;16(10):620\u201331.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1189_CR70","doi-asserted-by":"publisher","first-page":"8958","DOI":"10.1038\/s41598-019-45231-x","volume":"9","author":"C Marosi","year":"2019","unstructured":"Marosi C, Fodor Z, Csukly G. From basic perception deficits to facial affect recognition impairments in schizophrenia. Sci Rep. 2019;9(1):8958.","journal-title":"Sci Rep"},{"issue":"3","key":"1189_CR71","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","volume":"79","author":"WJ Jansen","year":"2022","unstructured":"Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, et al. Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum. JAMA Neurol. 2022;79(3):228\u201343.","journal-title":"JAMA Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01189-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01189-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01189-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:30:23Z","timestamp":1677756623000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01189-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01189-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the institutional review boards of Columbia University and New York State Psychiatric Institute. All individuals signed written informed consent following a full explanation of the study procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DCJ, AM, and YS have filed intellectual property for use of visual ERP in the early detection of AD based on these results. DCJ also holds intellectual property for use of NMDAR agonists in schizophrenia, NMDAR antagonists in depression and PTSD, and MR-guided ECT and TMS treatment. DCJ is a scientific advisor to SK Life Sci, Biogen, and Boehringer Ingelheim; holds intellectual property for NMDAR-based treatment of schizophrenia and depression and in the use of parcel-guided TMS in depression; and holds equity in Glytech, Amino Acid Solutions, and NRx Pharma. DPD has received research grants from the National Institute on Aging and the Alzheimer\u2019s Association and is a scientific adviser to Acadia, Biogen, Eisai, Genentech, Jazz Pharmaceuticals, and Novo Nordisk. YS is a scientific advisor to Eisai and Novic.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}